LongNow/others: IF NEU wants to get real investors' recognition as well as a better share-price, it will have to do a secondary listing outside the ASX, i.e. for instance in the USA, where institutions will have a much better appreciation in regard to biotechs and their correct value proposition and hence pricing. JIMHO, of course!
wasa
Success!!! Go NEU!!!, page-22
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.33 |
Change
-0.240(1.45%) |
Mkt cap ! $2.087B | |||
| Open | High | Low | Value | Volume |
| $16.49 | $16.62 | $15.60 | $11.97M | 733.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 403 | $16.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.42 | 1763 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |